Published in Biol Psychiatry on May 01, 2005
Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci (2009) 2.78
The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci (2006) 2.46
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol (2010) 1.71
Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci (2008) 1.54
Imaging the addicted human brain. Sci Pract Perspect (2007) 1.45
Chronic Methamphetamine Effects on Brain Structure and Function in Rats. PLoS One (2016) 1.43
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain (2010) 1.35
Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol (2011) 1.29
Potential adverse effects of amphetamine treatment on brain and behavior: a review. Mol Psychiatry (2008) 1.25
Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs (2010) 1.24
Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol (2012) 1.23
Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage (2010) 1.23
Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology (2011) 1.21
Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend (2012) 1.20
Impaired time perception and motor timing in stimulant-dependent subjects. Drug Alcohol Depend (2007) 1.19
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction. Ann N Y Acad Sci (2010) 1.17
The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev (2007) 1.15
Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol (2013) 1.15
Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend (2014) 1.13
An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology (2012) 1.09
Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence. Biol Psychiatry (2012) 1.02
Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology (Berl) (2013) 1.02
Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Neurosci Biobehav Rev (2012) 1.01
Methamphetamine users show greater than normal age-related cortical gray matter loss. Addiction (2011) 0.99
Sex differences in sensory gating of the thalamus during auditory interference of visual attention tasks. Neuroscience (2007) 0.98
Neuropsychological deficits in adolescent methamphetamine abusers. Psychopharmacology (Berl) (2010) 0.98
Abnormal striatal circuitry and intensified novelty seeking among adolescents who abuse methamphetamine and cannabis. Dev Neurosci (2012) 0.95
(+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats. Synapse (2008) 0.93
Increased ventral striatal volume in college-aged binge drinkers. PLoS One (2013) 0.91
Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users. Psychiatry Res (2009) 0.91
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol (2013) 0.91
Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol (2010) 0.91
Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals. Addiction (2013) 0.89
Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci (2009) 0.88
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res (2014) 0.87
Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol (2009) 0.87
Neuroimmune basis of methamphetamine toxicity. Int Rev Neurobiol (2014) 0.86
Cerebral gray matter volumes and low-frequency fluctuation of BOLD signals in cocaine dependence: duration of use and gender difference. Drug Alcohol Depend (2013) 0.85
Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance. Brain Sci (2012) 0.84
Subcortical volumes are reduced in short-term and long-term abstinent alcoholics but not those with a comorbid stimulant disorder. Neuroimage Clin (2013) 0.83
Withdrawal from long-term methamphetamine self-administration 'normalizes' neurometabolites in rhesus monkeys: a (1) H MR spectroscopy study. Addict Biol (2013) 0.83
The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen. Psychopharmacology (Berl) (2008) 0.82
The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina. Am J Addict (2011) 0.82
Mapping abnormal subcortical brain morphometry in an elderly HIV + cohort. Neuroimage Clin (2015) 0.80
Age and sex effects levels of choline compounds in the anterior cingulate cortex of adolescent methamphetamine users. Drug Alcohol Depend (2011) 0.80
Experience of road and other trauma by the opiate dependent patient: a survey report. Subst Abuse Treat Prev Policy (2008) 0.79
Sex differences in impulsivity and brain morphometry in methamphetamine users. Brain Struct Funct (2016) 0.79
An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research. Curr Drug Abuse Rev (2015) 0.79
Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval. Aust N Z J Psychiatry (2012) 0.79
Myelin, copper, and the cuprizone model of schizophrenia. Front Biosci (Schol Ed) (2011) 0.79
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy. Pharmacol Ther (2013) 0.79
Functional interactions of HIV-infection and methamphetamine dependence during motor programming. Psychiatry Res (2012) 0.78
Methamphetamine induces striatal cell death followed by the generation of new cells and a second round of cell death in mice. Curr Neuropharmacol (2011) 0.78
Neuropsychological Consequences of Chronic Drug Use: Relevance to Treatment Approaches. Front Psychiatry (2016) 0.78
Cannabis, Cigarettes, and Their Co-Occurring Use: Disentangling Differences in Gray Matter Volume. Int J Neuropsychopharmacol (2015) 0.78
Functional and structural brain changes associated with methamphetamine abuse. Brain Sci (2012) 0.77
The role of the GABA system in amphetamine-type stimulant use disorders. Front Cell Neurosci (2015) 0.77
Morphometric abnormalities of the lateral ventricles in methamphetamine-dependent subjects. Drug Alcohol Depend (2013) 0.76
A single high dose of methamphetamine induces apoptotic and necrotic striatal cell loss lasting up to 3 months in mice. Neuroscience (2011) 0.76
Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging. Psychiatry Res (2016) 0.76
Methamphetamine induces low levels of neurogenesis in striatal neuron subpopulations and differential motor performance. Neurotox Res (2014) 0.76
Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behav Brain Res (2015) 0.76
Disrupted iron regulation in the brain and periphery in cocaine addiction. Transl Psychiatry (2017) 0.75
Structural Neuroimaging in Polysubstance Users. Curr Opin Behav Sci (2017) 0.75
Comparative Study of the Activity of Brain Behavioral Systems in Methamphetamine and Opiate Dependents. Int J High Risk Behav Addict (2016) 0.75
Psychological intervention with working memory training increases basal ganglia volume: A VBM study of inpatient treatment for methamphetamine use. Neuroimage Clin (2016) 0.75
Frontal and striatal alterations associated with psychopathic traits in adolescents. Psychiatry Res (2015) 0.75
Neurobiological correlates of the familial risk for stimulant drug dependence. Neuropsychopharmacology (2013) 0.75
Sex disparities in substance abuse research: Evaluating 23 years of structural neuroimaging studies. Drug Alcohol Depend (2017) 0.75
Nupr1 Modulates Methamphetamine-Induced Dopaminergic Neuronal Apoptosis and Autophagy through CHOP-Trib3-Mediated Endoplasmic Reticulum Stress Signaling Pathway. Front Mol Neurosci (2017) 0.75
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci (2004) 4.14
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology (2000) 2.26
Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci (1999) 2.13
Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry (1998) 2.09
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res (2002) 2.02
Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology (2002) 1.76
Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis (2002) 1.63
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine. Lancet (1995) 1.43
Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol Psychiatry (1999) 1.37
Quantitative morphology of the caudate and putamen in patients with cocaine dependence. Am J Psychiatry (2001) 1.30
Why is parkinsonism not a feature of human methamphetamine users? Brain (2003) 1.29
A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci (1992) 1.25
Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J Neurobiol (1999) 1.16
Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord (2002) 1.15
Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res Monogr (1996) 1.14
Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. J Neurovirol (2004) 1.08
Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res (2003) 1.06
Increased basal ganglia volumes in velo-cardio-facial syndrome (deletion 22q11.2). Biol Psychiatry (2002) 1.04
Protein phosphorylation cascades associated with methamphetamine-induced glial activation. Ann N Y Acad Sci (2000) 1.03
Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug. Neurosci Lett (2003) 0.98
Gender differences in methamphetamine-induced mRNA associated with neurodegeneration in the mouse nigrostriatal dopaminergic system. Neuroendocrinology (2003) 0.90
Robust multimodality registration for brain mapping. Hum Brain Mapp (1997) 0.90
Midline cerebral morphometry distinguishes frontotemporal dementia and Alzheimer's disease. Neurology (1997) 0.89
Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Arch Gen Psychiatry (2002) 0.86
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood (2005) 6.05
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood (2009) 3.69
Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry (2007) 3.33
Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction (2007) 2.49
Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage (2011) 2.41
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS (2007) 2.09
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res (2002) 2.02
Common deactivation patterns during working memory and visual attention tasks: an intra-subject fMRI study at 4 Tesla. Hum Brain Mapp (2006) 1.96
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms. Blood (2011) 1.90
Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry (2005) 1.86
Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients. Neuroimage (2002) 1.83
Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res (2004) 1.78
Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol (2004) 1.71
Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol (2003) 1.70
Measurement and correction of microscopic head motion during magnetic resonance imaging of the brain. PLoS One (2012) 1.67
Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain (2004) 1.61
Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis (2004) 1.55
Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav (2011) 1.53
Unified structural equation modeling approach for the analysis of multisubject, multivariate functional MRI data. Hum Brain Mapp (2007) 1.52
Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention. PLoS One (2009) 1.51
EZH2 mutational status predicts poor survival in myelofibrosis. Blood (2011) 1.45
Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol (2004) 1.44
Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol (2008) 1.44
Regional patterns of brain metabolites in AIDS dementia complex. Neuroimage (2004) 1.40
Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci (2007) 1.39
Comprehensive mutational profiling in advanced systemic mastocytosis. Blood (2013) 1.35
Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage (2008) 1.35
Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antivir Ther (2003) 1.34
A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging (2003) 1.34
k-Space based summary motion detection for functional magnetic resonance imaging. Neuroimage (2003) 1.33
Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir Ther (2004) 1.30
Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (2011) 1.27
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy. Haematologica (2010) 1.26
Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. J Int Neuropsychol Soc (2008) 1.26
Prospective motion correction for single-voxel 1H MR spectroscopy. Magn Reson Med (2010) 1.22
Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging (2007) 1.20
Resistance to targeted therapy in chronic myelogenous leukemia. Semin Hematol (2007) 1.20
A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging (2005) 1.17
Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol (2013) 1.15
Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry (2007) 1.12
Lower cognitive reserve in the aging human immunodeficiency virus-infected brain. Neurobiol Aging (2012) 1.11
Effects of age and sex on brain glutamate and other metabolites. Magn Reson Imaging (2008) 1.10
Phospho-CRKL monitoring for the assessment of BCR-ABL activity in imatinib-resistant chronic myeloid leukemia or Ph+ acute lymphoblastic leukemia patients treated with nilotinib. Haematologica (2008) 1.08
Prospective motion correction for magnetic resonance spectroscopy using single camera Retro-Grate reflector optical tracking. J Magn Reson Imaging (2011) 1.07
Three-dimensional Fourier encoding of simultaneously excited slices: generalized acquisition and reconstruction framework. Magn Reson Med (2013) 1.07
Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry (2003) 1.04
Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol (2010) 1.04
Pediatric emergency department suicidal patients: two-site evaluation of suicide ideators, single attempters, and repeat attempters. J Am Acad Child Adolesc Psychiatry (2008) 1.01
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals. Haematologica (2009) 1.01
Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis. Haematologica (2010) 1.01
Echo planar imaging at 4 Tesla with minimum acoustic noise. J Magn Reson Imaging (2003) 1.00
Methamphetamine users show greater than normal age-related cortical gray matter loss. Addiction (2011) 0.99
TNFα-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection. PLoS Pathog (2013) 0.99
Neuropsychological deficits in adolescent methamphetamine abusers. Psychopharmacology (Berl) (2010) 0.98
Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls. BMC Psychiatry (2007) 0.98
Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict (2008) 0.98
Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women. PLoS One (2012) 0.97
Impact of BCR-ABL mutations on patients with chronic myeloid leukemia. Cell Cycle (2011) 0.97
Fast noniterative calibration of an external motion tracking device. Magn Reson Med (2013) 0.97
The human immunodeficiency virus reduces network capacity: acoustic noise effect. Ann Neurol (2006) 0.96
Prometheus--a new extracorporeal system for the treatment of liver failure. J Hepatol (2003) 0.95
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis. Ann Hematol (2013) 0.94
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clin Trials (2007) 0.94
Neurologic disorders incidence in HIV+ vs HIV- men: Multicenter AIDS Cohort Study, 1996-2011. Neurology (2012) 0.93
Localized in vivo human 1H MRS at very short echo times. Magn Reson Med (2004) 0.92
Phase contrast imaging in neonates. Neuroimage (2011) 0.92
Real-time dynamic frequency and shim correction for single-voxel magnetic resonance spectroscopy. Magn Reson Med (2012) 0.91
Higher diffusion in striatum and lower fractional anisotropy in white matter of methamphetamine users. Psychiatry Res (2009) 0.91
Memantine for AIDS dementia complex: open-label report of ACTG 301. HIV Clin Trials (2010) 0.91
Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals. J Neurovirol (2010) 0.91
Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase. J Cancer Res Clin Oncol (2014) 0.90
Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci (2011) 0.90
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia. Haematologica (2012) 0.89
Building infrastructure for HIV/AIDS and mental health research at institutions serving minorities. Am J Public Health (2009) 0.89
The effect of small rotations on R2* measured with echo planar imaging. Neuroimage (2005) 0.89
Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol (2010) 0.88
The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: rationale, psychometrics, and application. J Clin Exp Neuropsychol (2009) 0.87
mRNA expression of platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response to cetuximab-based chemoradiotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys (2008) 0.87
MRI default mode network connectivity is associated with functional outcome after cardiopulmonary arrest. Neurocrit Care (2014) 0.86
Identification of HIV-associated progressive multifocal leukoencephalopathy: magnetic resonance imaging and spectroscopy. J Neuropsychiatry Clin Neurosci (2003) 0.86
Prevention of motion-induced signal loss in diffusion-weighted echo-planar imaging by dynamic restoration of gradient moments. Magn Reson Med (2013) 0.86
Cause and management of therapy resistance. Best Pract Res Clin Haematol (2009) 0.86
Activating CBL mutations are associated with a distinct MDS/MPN phenotype. Ann Hematol (2012) 0.86
Removal selectivity of Prometheus: a new extracorporeal liver support device. World J Gastroenterol (2006) 0.85
The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif (2005) 0.85
The longitudinal and interactive effects of HIV status, stimulant use, and host genotype upon neurocognitive functioning. J Neurovirol (2014) 0.85
Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adults. Am J Med Genet B Neuropsychiatr Genet (2012) 0.84
No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death. J Neurovirol (2014) 0.84
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon α. Haematologica (2010) 0.83